Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
42
NCT04521075
A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC
Phase: Phase 1/2
Role: Lead Sponsor
Start: Nov 1, 2020
Completion: Jul 1, 2023